35 studies found for:    Thimerosal
Show Display Options
Rank Status Study
21 Completed
Has Results
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults
Condition: Influenza Caused by the Novel Influenza A (H1N1) Virus
Intervention: Biological: CSL425
22 Completed
Has Results
Influenza Vaccine in Pregnant Women
Condition: Influenza
Interventions: Biological: Fluzone®;   Biological: Fluarix®
23 Completed Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine
Condition: Healthy
Interventions: Biological: DTP/HB/Hib vaccine;   Biological: DTP/HB and Hib vaccine
24 Recruiting A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.
Condition: Influenza, Human
Interventions: Biological: Quadrivalent Influenza Vaccine (QIV);   Biological: Trivalent Influenza Vaccine (TIV-1);   Biological: Trivalent Influenza Vaccine (TIV-2)
25 Completed
Has Results
2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women
Condition: Influenza
Intervention: Biological: Trivalent Inactivated Influenza Vaccine
26 Completed
Has Results
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)
Condition: Novel 2009 Influenza H1N1
Interventions: Biological: MF59-eH1N1_f;   Biological: eH1N1_f
27 Completed
Has Results
A Study to Assess the Immunogenicity and Safety of CSL's 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers
Condition: Influenza, Human
Intervention: Biological: Enzira® vaccine
28 Completed The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)
Condition: Healthy
Intervention: Biological: DPT/HepatitisB/Hib vaccine
29 Completed
Has Results
Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants
Condition: Typhoid Fever
Interventions: Biological: Vi-rEPA conjugate vaccine for typhoid fever;   Biological: Hib-TT;   Biological: DTP
30 Completed 9-valent CRM 197 Pneumococcal
Condition: Pneumococcal Infections
Interventions: Biological: Nine-valent pneumococcal conjugate (PNCRM9);   Biological: PNU-IMUNE®23;   Drug: Placebo
31 Completed Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59
Condition: Influenza
Interventions: Biological: MF-59;   Biological: A/Anhui/05;   Drug: Placebo
32 Not yet recruiting A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Condition: Influenza, Human
Interventions: Biological: bioCSL Trivalent Influenza Virus Vaccine (CSL TIV);   Biological: Comparator Trivalent Influenza Virus Vaccine
33 Completed
Has Results
A Study to Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers
Condition: Influenza, Human
Intervention: Biological: Trivalent Influenza Vaccine
34 Completed
Has Results
A Study to Assess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® Vaccine in Healthy Volunteers
Condition: Influenza, Human
Intervention: Biological: CSL Influenza Vaccine
35 Not yet recruiting Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers
Condition: Pneumonia, Pneumococcal
Interventions: Biological: PATH-wSP;   Biological: pneumococcal polysaccharide conjugate vaccine (adsorbed);   Biological: Diptheria Pertussis Tetanus Hep B Haemophilus b Conjugate;   Other: Saline

Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page
Indicates status has not been verified in more than two years